slayerbing personal page - To The Moon

slayerbing

slayerbing

No personal profile

5Follow

0Followers

0Topic

0Badge

2021-07-26

Omg

@Joanne1135:$Caladrius Biosciences(CLBS)$[噴血] [噴血] sigh

2021-07-23

Hope can upup

Neovasc Announces New Appointments in Regulatory and Clinical Leadership

2021-02-25

?

Sorry, the original content has been removed

2021-02-25

To the moon

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3566121323062550","uuid":"3566121323062550","gmtCreate":1613741245948,"gmtModify":1616725931425,"name":"slayerbing","pinyin":"slayerbing","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":800444033,"gmtCreate":1627314861222,"gmtModify":1703487531542,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566121323062550","idStr":"3566121323062550"},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800444033","repostId":"171088038","repostType":1,"repost":{"id":171088038,"gmtCreate":1626696075224,"gmtModify":1703763490010,"author":{"id":"3574327149519440","authorId":"3574327149519440","name":"Joanne1135","avatar":"https://static.tigerbbs.com/5904dcff1de1f030ce21934cc218d4ac","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574327149519440","idStr":"3574327149519440"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLBS\">$Caladrius Biosciences(CLBS)$</a>[噴血]&nbsp;[噴血]&nbsp;sigh","listText":"<a href=\"https://laohu8.com/S/CLBS\">$Caladrius Biosciences(CLBS)$</a>[噴血]&nbsp;[噴血]&nbsp;sigh","text":"$Caladrius Biosciences(CLBS)$[噴血] [噴血] sigh","images":[{"img":"https://static.tigerbbs.com/d898c57095d7dd52142244761e3e0364","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171088038","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175408650,"gmtCreate":1627044884170,"gmtModify":1703483128188,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566121323062550","idStr":"3566121323062550"},"themes":[],"htmlText":"Hope can upup","listText":"Hope can upup","text":"Hope can upup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175408650","repostId":"2151566077","repostType":2,"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361659582,"gmtCreate":1614231240146,"gmtModify":1704889920613,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566121323062550","idStr":"3566121323062550"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/361659582","repostId":"2114392599","repostType":2,"repost":{"id":"2114392599","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614212913,"share":"https://ttm.financial/m/news/2114392599?lang=&edition=fundamental","pubTime":"2021-02-25 08:28","market":"hk","language":"en","title":"Asian open higher as Fed's Powell nixes inflation fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2114392599","media":"Reuters","summary":"MIAMI, Feb 24 (Reuters) - Asian stocks perked up on Thursday after U.S. Federal Reserve Chair Jerome","content":"<p>MIAMI, Feb 24 (Reuters) - Asian stocks perked up on Thursday after U.S. Federal Reserve Chair Jerome Powell reaffirmed interest rates would stay low, calming market fears that higher inflation might prompt the central bank to tighten the monetary spigot.</p>\n<p>\"The dovish influence from the Fed is going to continue to resonate over in Asia. That's really good for emerging market assets when we've got a really good impulse from the Fed,\" said Stephen Innes, chief global markets strategist at Axi.</p>\n<p>Australia's S&amp;P/ASX 200 rose 0.90% in early trade while Japan's Nikkei 225 added 1.37%. Hong Kong's Hang Seng index futures rose 0.92%.</p>\n<p>In a second day of testimony in Washington, Powell reiterated the Fed's promise to get the U.S. economy back to full employment and to not worry about inflation unless prices rose in a persistent and troubling way.</p>\n<p>Crude oil climbed to fresh 13-month highs after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.</p>\n<p>Gold prices struggled for traction as elevated Treasury yields eroded the allure of bullion as an inflation hedge.</p>\n<p>The dollar hit fresh three-year lows against the pound and commodity-linked currencies including the Canadian, Australian and New Zealand dollars, which are expected to benefit from a pick-up in global trade as growth rebounds.</p>\n<p>MSCI's gauge of stocks across the globe gained 0.12%, as rising stocks on Wall Street pushed the global benchmark to reverse early losses.</p>\n<p>The Dow Jones Industrial Average set a record high rising 1.35% to 31,961.86 while the S&amp;P 500 gained 1.14%. The Nasdaq index, which fell as much as 1.3% earlier in the session, regained its footing by early afternoon and closed up 0.99%.</p>\n<p>Shares of GameStop Corp, at the center of a volatile retail trading frenzy moves in late January, more than doubled in price in late trading and continued to soar in heavy, post-market trade.</p>\n<p>The U.S. Food and Drug Administration said on Wednesday Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/AONE\">one</a>-dose COVID-19 vaccine appeared safe and effective in trials, paving the way for its approval for emergency use as soon as this week.</p>\n<p>Johnson &amp; Johnson rose 1.3% following the news, seen as another boost to a strong recovery.</p>\n<p>The dollar index fell 0.083%, with the euro up 0.02% to $1.2167. The Japanese yen weakened 0.03% versus the greenback at 105.91 per dollar.</p>\n<p>Oil prices rose after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.</p>\n<p>U.S. crude recently rose 0.3% to $63.41 per barrel and Brent was at $67.31, up 2.97% on the day.</p>\n<p>Spot gold dropped 0.1% to $1,802.72 an ounce. U.S. gold futures gained 0.30% to $1,802.00 an ounce.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Asian open higher as Fed's Powell nixes inflation fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAsian open higher as Fed's Powell nixes inflation fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-25 08:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MIAMI, Feb 24 (Reuters) - Asian stocks perked up on Thursday after U.S. Federal Reserve Chair Jerome Powell reaffirmed interest rates would stay low, calming market fears that higher inflation might prompt the central bank to tighten the monetary spigot.</p>\n<p>\"The dovish influence from the Fed is going to continue to resonate over in Asia. That's really good for emerging market assets when we've got a really good impulse from the Fed,\" said Stephen Innes, chief global markets strategist at Axi.</p>\n<p>Australia's S&amp;P/ASX 200 rose 0.90% in early trade while Japan's Nikkei 225 added 1.37%. Hong Kong's Hang Seng index futures rose 0.92%.</p>\n<p>In a second day of testimony in Washington, Powell reiterated the Fed's promise to get the U.S. economy back to full employment and to not worry about inflation unless prices rose in a persistent and troubling way.</p>\n<p>Crude oil climbed to fresh 13-month highs after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.</p>\n<p>Gold prices struggled for traction as elevated Treasury yields eroded the allure of bullion as an inflation hedge.</p>\n<p>The dollar hit fresh three-year lows against the pound and commodity-linked currencies including the Canadian, Australian and New Zealand dollars, which are expected to benefit from a pick-up in global trade as growth rebounds.</p>\n<p>MSCI's gauge of stocks across the globe gained 0.12%, as rising stocks on Wall Street pushed the global benchmark to reverse early losses.</p>\n<p>The Dow Jones Industrial Average set a record high rising 1.35% to 31,961.86 while the S&amp;P 500 gained 1.14%. The Nasdaq index, which fell as much as 1.3% earlier in the session, regained its footing by early afternoon and closed up 0.99%.</p>\n<p>Shares of GameStop Corp, at the center of a volatile retail trading frenzy moves in late January, more than doubled in price in late trading and continued to soar in heavy, post-market trade.</p>\n<p>The U.S. Food and Drug Administration said on Wednesday Johnson &amp; Johnson's <a href=\"https://laohu8.com/S/AONE\">one</a>-dose COVID-19 vaccine appeared safe and effective in trials, paving the way for its approval for emergency use as soon as this week.</p>\n<p>Johnson &amp; Johnson rose 1.3% following the news, seen as another boost to a strong recovery.</p>\n<p>The dollar index fell 0.083%, with the euro up 0.02% to $1.2167. The Japanese yen weakened 0.03% versus the greenback at 105.91 per dollar.</p>\n<p>Oil prices rose after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.</p>\n<p>U.S. crude recently rose 0.3% to $63.41 per barrel and Brent was at $67.31, up 2.97% on the day.</p>\n<p>Spot gold dropped 0.1% to $1,802.72 an ounce. U.S. gold futures gained 0.30% to $1,802.00 an ounce.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"159934":"黄金ETF","518880":"黄金ETF",".IXIC":"NASDAQ Composite","UDOW":"道指三倍做多ETF-ProShares","QQQ":"纳指100ETF","GME":"游戏驿站","TQQQ":"纳指三倍做多ETF","SCO":"二倍做空彭博原油指数ETF","NUGT":"二倍做多黄金矿业指数ETF-Direxion",".SPX":"S&P 500 Index","YCS":"日元ETF-ProShares两倍做空","USO":"美国原油ETF","DOG":"道指反向ETF",".DJI":"道琼斯","QID":"纳指两倍做空ETF","DJX":"1/100道琼斯","DDG":"ProShares做空石油与天然气ETF","DUST":"二倍做空黄金矿业指数ETF-Direxion","SQQQ":"纳指三倍做空ETF","UCO":"二倍做多彭博原油ETF","FXY":"日元ETF-CurrencyShares","JNJ":"强生","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF","IAU":"黄金信托ETF(iShares)","GDX":"黄金矿业ETF-VanEck","FXE":"欧元做多ETF-CurrencyShares","DUG":"二倍做空石油与天然气ETF(ProShares)","SDOW":"道指三倍做空ETF-ProShares","GLD":"SPDR黄金ETF","DDM":"道指两倍做多ETF","DWT":"三倍做空原油ETN","PSQ":"纳指反向ETF","EUO":"欧元ETF-ProShares两倍做空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114392599","content_text":"MIAMI, Feb 24 (Reuters) - Asian stocks perked up on Thursday after U.S. Federal Reserve Chair Jerome Powell reaffirmed interest rates would stay low, calming market fears that higher inflation might prompt the central bank to tighten the monetary spigot.\n\"The dovish influence from the Fed is going to continue to resonate over in Asia. That's really good for emerging market assets when we've got a really good impulse from the Fed,\" said Stephen Innes, chief global markets strategist at Axi.\nAustralia's S&P/ASX 200 rose 0.90% in early trade while Japan's Nikkei 225 added 1.37%. Hong Kong's Hang Seng index futures rose 0.92%.\nIn a second day of testimony in Washington, Powell reiterated the Fed's promise to get the U.S. economy back to full employment and to not worry about inflation unless prices rose in a persistent and troubling way.\nCrude oil climbed to fresh 13-month highs after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.\nGold prices struggled for traction as elevated Treasury yields eroded the allure of bullion as an inflation hedge.\nThe dollar hit fresh three-year lows against the pound and commodity-linked currencies including the Canadian, Australian and New Zealand dollars, which are expected to benefit from a pick-up in global trade as growth rebounds.\nMSCI's gauge of stocks across the globe gained 0.12%, as rising stocks on Wall Street pushed the global benchmark to reverse early losses.\nThe Dow Jones Industrial Average set a record high rising 1.35% to 31,961.86 while the S&P 500 gained 1.14%. The Nasdaq index, which fell as much as 1.3% earlier in the session, regained its footing by early afternoon and closed up 0.99%.\nShares of GameStop Corp, at the center of a volatile retail trading frenzy moves in late January, more than doubled in price in late trading and continued to soar in heavy, post-market trade.\nThe U.S. Food and Drug Administration said on Wednesday Johnson & Johnson's one-dose COVID-19 vaccine appeared safe and effective in trials, paving the way for its approval for emergency use as soon as this week.\nJohnson & Johnson rose 1.3% following the news, seen as another boost to a strong recovery.\nThe dollar index fell 0.083%, with the euro up 0.02% to $1.2167. The Japanese yen weakened 0.03% versus the greenback at 105.91 per dollar.\nOil prices rose after U.S. government data showed a drop in crude output as a deep freeze disrupted production last week.\nU.S. crude recently rose 0.3% to $63.41 per barrel and Brent was at $67.31, up 2.97% on the day.\nSpot gold dropped 0.1% to $1,802.72 an ounce. U.S. gold futures gained 0.30% to $1,802.00 an ounce.","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361153518,"gmtCreate":1614215289334,"gmtModify":1704889642388,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566121323062550","idStr":"3566121323062550"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/361153518","repostId":"2114583391","repostType":2,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":800444033,"gmtCreate":1627314861222,"gmtModify":1703487531542,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566121323062550","authorIdStr":"3566121323062550"},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800444033","repostId":"171088038","repostType":1,"repost":{"id":171088038,"gmtCreate":1626696075224,"gmtModify":1703763490010,"author":{"id":"3574327149519440","authorId":"3574327149519440","name":"Joanne1135","avatar":"https://static.tigerbbs.com/5904dcff1de1f030ce21934cc218d4ac","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574327149519440","authorIdStr":"3574327149519440"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLBS\">$Caladrius Biosciences(CLBS)$</a>[噴血]&nbsp;[噴血]&nbsp;sigh","listText":"<a href=\"https://laohu8.com/S/CLBS\">$Caladrius Biosciences(CLBS)$</a>[噴血]&nbsp;[噴血]&nbsp;sigh","text":"$Caladrius Biosciences(CLBS)$[噴血] [噴血] sigh","images":[{"img":"https://static.tigerbbs.com/d898c57095d7dd52142244761e3e0364","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171088038","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175408650,"gmtCreate":1627044884170,"gmtModify":1703483128188,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566121323062550","authorIdStr":"3566121323062550"},"themes":[],"htmlText":"Hope can upup","listText":"Hope can upup","text":"Hope can upup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175408650","repostId":"2151566077","repostType":2,"repost":{"id":"2151566077","pubTimestamp":1626181500,"share":"https://ttm.financial/m/news/2151566077?lang=&edition=fundamental","pubTime":"2021-07-13 21:05","market":"us","language":"en","title":"Neovasc Announces New Appointments in Regulatory and Clinical Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2151566077","media":"Newsfile","summary":"Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global ","content":"<div>\n<p>Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs\nVancouver, British Columbia and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/neovasc-announces-appointments-regulatory-clinical-130500462.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neovasc Announces New Appointments in Regulatory and Clinical Leadership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeovasc Announces New Appointments in Regulatory and Clinical Leadership\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-13 21:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/neovasc-announces-appointments-regulatory-clinical-130500462.html><strong>Newsfile</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs\nVancouver, British Columbia and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/neovasc-announces-appointments-regulatory-clinical-130500462.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/XwkoJlQ8YeaHG5lPQvNdJQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/ww_GrDD7aKzaRSlsgGdndA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/6701dee067c7330d67b99fcb8cf47504","relate_stocks":{"NVCN":"Neovasc Inc","NGD":"New Gold"},"source_url":"https://finance.yahoo.com/news/neovasc-announces-appointments-regulatory-clinical-130500462.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2151566077","content_text":"Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs\nVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 13, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) (\"Neovasc\" or the \"Company\") announced today that it has appointed Lisa Becker as Vice President, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as Vice President, Clinical Affairs.\n\"Neovasc's Regulatory and Clinical teams will be well strengthened with the additions of Lisa and Sarah, who bring tremendous experience in regulatory and clinical affairs to the overall Neovasc team,\" said Fred Colen, President and Chief Executive Officer of Neovasc. \"We look forward to leveraging their industry expertise as we pursue our own development goals in North America and Europe.\"\nMs. Becker has more than 20 years of experience in medical device regulatory affairs. Her product and therapy experience has spanned medical devices from cardiac rhythm management, to vascular support, pulmonary artery pressure monitoring, cardiac occluders, heart valves and most recently, structural heart products, previously working at Abbott, St. Jude Medical, Boston Scientific and Guidant. She possesses regulatory experience on a global scale, with responsibility for multiple geographies, including US and EU Class III approvals. Ms. Becker earned a Bachelor of Science in Organizational Behavior with a General Engineering minor from the United States Air Force Academy and a Masters of Science from Chapman University. She served nearly ten years on active duty as an officer in the US Air Force. A highlight of Ms. Becker's career includes the approval of the world's smallest mechanical heart valve and a duct occluder for premature infants, which was approved in four major geographies within a six-month period.\n\"I view my regulatory work as a continuation of my service toward improving lives. As a member of the Neovasc team, I will bring my professional passion for driving medical device development through creative and collaborative regulatory approval strategies to the Company's efforts to expand approval and acceptance of the Reducer device,\" said Ms. Becker. \nMs. Gallagher brings 20 years of medical device clinical research experience to the Neovasc team. Prior to joining Neovasc, she held leadership roles at Medtronic in Interventional Pain, Neuromodulation, and Cardiac Rhythm Management, as well as St. Jude Medical in Structural Heart. During her tenure she held roles with increasing responsibility in clinical research and clinical operations, and she has developed and executed both pre- and post-market clinical trials and supported regulatory approvals globally. Ms. Gallagher holds a Bachelor of Applied Arts in Exercise Science and a Bachelor of Arts in Psychology from the University of Minnesota, and Master of Science in Technology Management from the University of St. Thomas.\n\"I am excited to be joining the Neovasc Clinical Affairs team at this critical point in the Company's corporate and clinical journey,\" said Ms. Gallagher. \"I am eager to engage in the ongoing and new studies and data supporting the Reducer and Tiara programs, as we seek to bring these important treatment options to more patients.\" \nNeovasc also announces the departure of Vicki Bebeau, former Vice President of Clinical and Regulatory affairs who is assisting with transitioning activities to Sarah and Lisa until August 30, 2021.\nAbout Neovasc Inc.\nNeovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and Tiara, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. For more information, visit: www.neovasc.com.\nForward-Looking Statement Disclaimer\nCertain statements in this news release contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws that may not be based on historical fact. When used herein, the words \"expect\", \"anticipate\", \"estimate\", \"may\", \"will\", \"should\", \"intend,\" \"believe\", and similar expressions, are intended to identify forward-looking statements. Forward-looking statements may involve, but are not limited to, the Company's regulatory and clinical team being strengthened with the additions of Ms. Becker and Ms. Gallagher, leveraging the industry experience of Ms. Becker and Ms. Gallagher to pursue the Company's development goals in North America and Europe, Ms. Becker's plans of bringing collaborative regulatory approval strategies to the Company's efforts to expand approval and acceptance of the Reducer device, Ms. Gallagher's plans to engage in ongoing and new studies and data supporting the Reducer and Tiara programs and seeking to bring these treatment options to more patients and the growing cardiovascular marketplace. Forward-looking statements are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, market and other conditions as well as other factors that the Company believes are appropriate in the circumstances. Many factors could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including those described in the \"Risk Factors\" section of the Company's Annual Information Form and in the Management's Discussion and Analysis for the three months ended March 30, 2021 (copies of which may be obtained at www.sedar.com or www.sec.gov). These factors should be considered carefully, and readers should not place undue reliance on the Company's forward-looking statements. The Company has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.\nInvestors\nMike CavanaughWestwicke/ICRPhone: +1.646.877.9641Mike.Cavanaugh@westwicke.com\nMedia\nSean LeousWestwicke/ICRPhone: +1.646.866.4012Sean.Leous@westwicke.com\n\nTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/90068","news_type":1},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361659582,"gmtCreate":1614231240146,"gmtModify":1704889920613,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566121323062550","authorIdStr":"3566121323062550"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/361659582","repostId":"2114392599","repostType":2,"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":361153518,"gmtCreate":1614215289334,"gmtModify":1704889642388,"author":{"id":"3566121323062550","authorId":"3566121323062550","name":"slayerbing","avatar":"https://static.tigerbbs.com/d4ee1324e4ccf4d6f874ce1c503b8550","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566121323062550","authorIdStr":"3566121323062550"},"themes":[],"htmlText":"To the moon","listText":"To the moon","text":"To the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/361153518","repostId":"2114583391","repostType":2,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}